Scarborough Advisors’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-207
Closed -$14.7K 351
2026
Q1
$14.7K Buy
207
+80
+63% +$6.31K ﹤0.01% 386
2025
Q4
$10.4K Buy
127
+24
+23% +$1.87K ﹤0.01% 262
2025
Q3
$7.74K Hold
103
﹤0.01% 273
2025
Q2
$7.63K Buy
+103
New +$7.17K ﹤0.01% 262
2024
Q3
Sell
-154
Closed -$12K 256
2024
Q2
$12K Buy
154
+101
+191% +$8.24K ﹤0.01% 197
2024
Q1
$4.82K Hold
53
﹤0.01% 260
2023
Q4
$4.1K Buy
+53
New +$3.71K ﹤0.01% 498

Other funds holding GEHC

Scarborough Advisors's GEHC Position: Q2 2026 in Review

Scarborough Advisors sold out of GE HealthCare (GEHC) in Q2 2026, closing a stake of 207 shares — an estimated $14.7K sold.

Scarborough Advisors first reported a position in GEHC in Q4 2023 and held it in 7 quarters. The position peaked at $14.7K in Q1 2026. 1,223 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Scarborough Advisors reported no remaining GE HealthCare position as of Q2 2026 after selling out during the quarter.
  • Scarborough Advisors sold 207 GE HealthCare shares in Q2 2026, an estimated $14.7K.
  • Scarborough Advisors first reported a position in GE HealthCare in Q4 2023 and held it in 7 quarters.
  • Scarborough Advisors's GE HealthCare position peaked at $14.7K in Q1 2026.
  • 1,223 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Scarborough Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.